NON-INVASIVE LUNG IMPEDANCE-GUIDED PREEMPTIVE TREATMENT IN CHRONIC HEART FAILURE PATIENTS: A RANDOMIZED CONTROLLED TRIAL (IMPEDANCE-HF TRIAL)

Previous investigations have suggested that lung impedance (LI)-guided treatment reduces hospitalizations for acute heart failure (HF). A single-blind two-center trial was performed to evaluate this hypothesis. Study population included 256 patients from 2 medical centers with CHF and LVEF ≤35%